BCHE and Alzheimer disease: The initial AD symptoms (i.e., cognitive impairment, memory loss, and learning deficits) appear to be related to the loss of cholinergic innervation in the cerebral cortex, leading to the formulation of the “Cholinergic Hypothesis of AD” [3,4] and the development of cholinesterase inhibitor-based therapies.